ScreenIT

Latest preprint reviews

1. Antibody Response to COVID-19 mRNA Vaccine in Patients With Lung Cancer After Primary Immunization and Booster: Reactivity to the SARS-CoV-2 WT Virus and Omicron Variant

   This article has 39 authors:

   1. Rajesh M. Valanparambil
   2. Jennifer Carlisle
   3. Susanne L. Linderman
   4. Akil Akthar
   5. Ralph Linwood Millett
   6. Lilin Lai
   7. Andres Chang
   8. Ashley A. McCook-Veal
   9. Jeffrey Switchenko
   10. Tahseen H. Nasti
   11. Manpreet Saini
   12. Andreas Wieland
   13. Kelly E. Manning
   14. Madison Ellis
   15. Kathryn M. Moore
   16. Stephanie L. Foster
   17. Katharine Floyd
   18. Meredith E. Davis-Gardner
   19. Venkata-Viswanadh Edara
   20. Mit Patel
   21. Conor Steur
   22. Ajay K. Nooka
   23. Felicia Green
   24. Margaret A. Johns
   25. Fiona O'Brein
   26. Uma Shanmugasundaram
   27. Veronika I. Zarnitsyna
   28. Hasan Ahmed
   29. Lindsay E. Nyhoff
   30. Grace Mantus
   31. Michael Garett
   32. Srilatha Edupuganti
   33. Madhusmita Behra
   34. Rustom Antia
   35. Jens Wrammert
   36. Mehul S. Suthar
   37. Madhav V. Dhodapkar
   38. Suresh Ramalingam
   39. Rafi Ahmed

   Reviewed by Rapid Reviews Infectious Diseases, ScreenIT

2. Mapping the antigenic diversification of SARS-CoV-2

   This article has 27 authors:

   1. Karlijn van der Straten
   2. Denise Guerra
   3. Marit J. van Gils
   4. Ilja Bontjer
   5. Tom G. Caniels
   6. Hugo D.G. van Willigen
   7. Elke Wynberg
   8. Meliawati Poniman
   9. Judith A. Burger
   10. Joey H. Bouhuijs
   11. Jacqueline van Rijswijk
   12. Wouter Olijhoek
   13. Marinus H. Liesdek
   14. A. H. Ayesha Lavell
   15. Brent Appelman
   16. Jonne J. Sikkens
   17. Marije K. Bomers
   18. Alvin X. Han
   19. Brooke E. Nichols
   20. Maria Prins
   21. Harry Vennema
   22. Chantal Reusken
   23. Menno D. de Jong
   24. Godelieve J. de Bree
   25. Colin A. Russell
   26. Dirk Eggink
   27. Rogier W. Sanders

   Reviewed by ScreenIT

3. Immunogenicity and safety of NVSI-06-07 as a heterologous booster after priming with BBIBP-CorV: a phase 2 trial

   This article has 38 authors:

   1. Nawal Al Kaabi
   2. Yun Kai Yang
   3. Jing Zhang
   4. Ke Xu
   5. Yu Liang
   6. Yun Kang
   7. Ji Guo Su
   8. Tian Yang
   9. Salah Hussein
   10. Mohamed Saif ElDein
   11. Shuai Shao
   12. Sen Sen Yang
   13. Wenwen Lei
   14. Xue Jun Gao
   15. Zhiwei Jiang
   16. Hui Wang
   17. Meng Li
   18. Hanadi Mekki Mekki
   19. Walid Zaher
   20. Sally Mahmoud
   21. Xue Zhang
   22. Chang Qu
   23. Dan Ying Liu
   24. Jing Zhang
   25. Mengjie Yang
   26. Islam Eltantawy
   27. Peng Xiao
   28. Zhao Nian Wang
   29. Jin Liang Yin
   30. Xiao Yan Mao
   31. Jin Zhang
   32. Ning Liu
   33. Fu Jie Shen
   34. Liang Qu
   35. Yun Tao Zhang
   36. Xiao Ming Yang
   37. Guizhen Wu
   38. Qi Ming Li

   Reviewed by ScreenIT

4. Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design

   This article has 25 authors:

   1. Houssein H Ayoub
   2. Milan Tomy
   3. Hiam Chemaitelly
   4. Heba N Altarawneh
   5. Peter Coyle
   6. Patrick Tang
   7. Mohammad R Hasan
   8. Zaina Al Kanaani
   9. Einas Al Kuwari
   10. Adeel A Butt
   11. Andrew Jeremijenko
   12. Anvar Hassan Kaleeckal
   13. Ali Nizar Latif
   14. Riyazuddin Mohammad Shaik
   15. Gheyath K Nasrallah
   16. Fatiha M Benslimane
   17. Hebah A Al Khatib
   18. Hadi M Yassine
   19. Mohamed G Al Kuwari
   20. Hamad Eid Al Romaihi
   21. Hanan F Abdul-Rahim
   22. Mohamed H Al-Thani
   23. Abdullatif Al Khal
   24. Roberto Bertollini
   25. Laith J Abu-Raddad

   Reviewed by ScreenIT

5. Nonself Mutations in the Spike Protein Suggest an Increase in the Antigenicity and a Decrease in the Virulence of the Omicron Variant of SARS-CoV-2

   This article has 3 authors:

   1. Joji M. Otaki
   2. Wataru Nakasone
   3. Morikazu Nakamura

   Reviewed by ScreenIT

6. Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates

   This article has 6 authors:

   1. Denisa Bojkova
   2. Marek Widera
   3. Sandra Ciesek
   4. Mark N. Wass
   5. Martin Michaelis
   6. Jindrich Cinatl

   Reviewed by ScreenIT

7. In vitro evaluation of therapeutic antibodies against a SARS-CoV-2 Omicron B.1.1.529 isolate

   This article has 4 authors:

   1. Franck Touret
   2. Cécile Baronti
   3. Hawa Sophia Bouzidi
   4. Xavier de Lamballerie

   Reviewed by ScreenIT

8. Integrated autolysis, DNA hydrolysis and precipitation enables an improved bioprocess for Q-Griffithsin, a broad-spectrum antiviral and clinical-stage anti-COVID-19 candidate

   This article has 3 authors:

   1. John S. Decker
   2. Romel Menacho-Melgar
   3. Michael D. Lynch

   Reviewed by ScreenIT

9. Hydrodynamics of spike proteins dictate a transport-affinity competition for SARS-CoV-2 and other enveloped viruses

   This article has 4 authors:

   1. Nicolas Moreno
   2. Daniela Moreno-Chaparro
   3. Florencio Balboa Usabiaga
   4. Marco Ellero

   Reviewed by ScreenIT

10. SARS-CoV-2 entry sites are present in all structural elements of the human glossopharyngeal and vagal nerves: Clinical implications

    This article has 5 authors:

    1. Lynn Vitale-Cross
    2. Ildiko Szalayova
    3. Aiden Scoggins
    4. Miklos Palkovits
    5. Eva Mezey

    Reviewed by ScreenIT